-
-
-
-
-
-
-
Aeterna Zentaris to Present at the 2017 BIO CEO and Investor Conference
-
-
-
-
-
-
-
Aeterna Zentaris (AEZS), Specialised Therapeutics Enter Zoptrex Licensing Agreement in Australia, New Zealand
-
-
-
-
-
-
-
Aeterna Zentaris (AEZS), Rafa Laboratories Sign License Agreement for Zoptrex in Israel
-
-
-
-
-
-
-
Aeterna Zentaris (AEZS) Remains Committed to LHRH-Receptor Targeted Therapy and Zoptrex
-
-
-
-
-
-
-
Aeterna Zentaris Acquires Exclusive U.S. Promotional Rights for APIFINY® Prostate Cancer Blood Test
-
-
-
-
-
-
-
Aeterna Zentaris (AEZS) Says Zoptrex CTA Submission to China SFDA is on Track
-
-
-
-
-
-
-
Aeterna Zentaris to Participate in 18th Annual BIO CEO & Investor Conference Seeking Partnering Opportunities
-
1,171,082 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

